Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-25T08:18:01.505Z Has data issue: false hasContentIssue false

The Effect of 5-HT2A/1a Agonist Treatment On Social Cognition, Empathy, and Social Decision-making

Published online by Cambridge University Press:  15 April 2020

K.H. Preller
Affiliation:
Department of Psychiatry Psychotherapy and Psychosomatics, University Hospital for Psychiatry Zurich, Zurich, Switzerland
T. Pokorny
Affiliation:
Department of Psychiatry Psychotherapy and Psychosomatics, University Hospital for Psychiatry Zurich, Zurich, Switzerland
R. Krähenmann
Affiliation:
Department of Psychiatry Psychotherapy and Psychosomatics, University Hospital for Psychiatry Zurich, Zurich, Switzerland
I. Dziobek
Affiliation:
Cluster Languages of Emotion, Freie Universität Berlin, Berlin, Germany
P. Stämpfli
Affiliation:
Department of Psychiatry Psychotherapy and Psychosomatics, University Hospital for Psychiatry Zurich, Zurich, Switzerland
F.X. Vollenweider
Affiliation:
Department of Psychiatry Psychotherapy and Psychosomatics, University Hospital for Psychiatry Zurich, Zurich, Switzerland

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Social cognition is a crucial factor influencing development, progress, and treatment of psychiatric disorders. However, social cognition skills are insufficiently targeted by current treatment approaches. In particular, patients suffering from depression show an increased negative reaction to social exclusion and deficits in empathy. The 5HT-1A/2A receptor agonist psilocybin has previously been shown to reduce the neural response to negative emotional stimuli. However, it is not known if this extends to negative social interaction and whether 5HT-1A/2A receptor stimulation induces changes in empathy. Given the clear need for improved treatment of socio-cognitive functioning in psychiatric disorders, it is important to better understand the neuronal and neuromodulatory substrates of social cognition.

In a double-blind, randomized, cross-over design we therefore investigated the neural response to ostracism after the acute administration of psilocybin (0.215mg/kg) and placebo in healthy volunteers using fMRI. Furthermore, we assessed cognitive and emotional empathy using the Multifaceted Empathy Test.

The neural response to social exclusion in the ACC – a brain region associated with ‘social pain”- was reduced after psilocybin administration compared to placebo. Furthermore, emotional empathy was enhanced after treatment with psilocybin while no significant differences were found in cognitive empathy.

These results show that the 5HT-1A/2A receptor subtypes play an important role in the modulation of socio-cognitive functioning and therefore may be relevant for the treatment of social cognition deficits in psychiatric disorders. In particular, they may be important for the normalization of empathy deficits and increased negative reaction to social exclusion in depressed patients.

Type
Article: 0022
Copyright
Copyright © European Psychiatric Association 2015
Submit a response

Comments

No Comments have been published for this article.